Nucleic acid testing for virus screening in Polish blood donors [3]

Transfusion Medicine

Volumn 14, Issue 1, 2004, Pages 79-80

  Brojer, E ^a,b   Letowska M ^b   Gronowska, A ^b  

^a Department of Immunohaematology ^*  (Poland)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; VIRUS RNA;

ACCURACY; ANALYTIC METHOD; BLOOD ANALYSIS; BLOOD DONOR; BLOOD TRANSFUSION; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABORATORY TEST; LETTER; POLAND; RNA ISOLATION;

BLOOD DONORS; HEPATITIS C; HUMANS; MASS SCREENING; NUCLEIC ACIDS; POLAND; RNA, VIRAL; VIRUS DISEASES;

EID: 1842665051     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0958-7578.2004.00484.x     Document Type: Letter

References (8)

1. Brojer, E., Liszewski, G., Niżnik, A., Rosiek, A. & Łȩtowska, M. (2001) Detection of HCV core antigen in HCV RNA positive, anti-HCV negative blood donations from Polish blood donors. Transfusion, 41, 304-305.
2. CPMP (1998) The introduction of nucleic acid amplification technology (NAT) for the detection of hepatitis C virus RNA in plasma pools. CPMP/BWP/390/97, EMEA, London.
3. Eglin, R. (2002) Implementation of genome amplification technology for HCV RNA detection. Transfusion medicine, 12, 265-273.
4. Jarvis, L.M. & Simmonds, P. (2002) Scottish experience with NAT. Transfusion medicine, 12, 259-264.
5. Roth, W.K. & Seifried, E. (2002) The German experience with NAT. Transfusion medicine, 12, 255-258.
6. Nubling, C.M., Unger, G., Chudy, M., Raia, S. & Lover, J. (2002) Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase. Transfusion, 42, 1037-1045.
7. Sabliński, J. & Łȩtowska, M. (2000) Krwiodawstwo i Krwiolecznictwo - Zbiór Przepisów. Ministerstwo Zdrowia, Krajowe Centrum Krwiodawstwa i Krwiolecznictwa, Instytut Hematologii, Warszawa.
8. Stramer, S.L. (2002) US NAT yield: where are we after 2 years. Transfusion medicine, 12, 243-253.